En las noticias
213 articles
New Study Shows Benefit of Chemotherapy after Surgery
Should you have adjuvant chemotherapy–treatment after pancreatic cancer surgery? Dr. Marco Del Chiaro explains that the evidence says “yes.”
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
Progress in BRCA-Related Cancers Highlighted By the Basser Center
The Basser Center for BRCA hosted a panel discussion of the latest breakthroughs and discoveries for BRCA-related cancers.
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
Common Anti-Anxiety Medications May Affect Outcomes
Many pancreatic cancer patients take anti-anxiety medications. But what you take may affect how your treatment works, says Dr. Michael Feigin.
Chemotherapy Plus Immunotherapy Trial Shows Promise
Dr. Gulam Manji leads a clinical trial that uses two types of immunotherapy to enhance chemotherapy for pancreatic cancer patients.